Advancing Microbiome Therapeutics Through Deep Clinical Datasets & Reverse Translational Approaches to Drive LBP Development Success
- Presenting recent Seres clinical trial insights demonstrating successful translation into previously inaccessible biology and disease targets unlocked by microbiome therapeutics
- Leveraging high-quality multi-omic clinical datasets and reverse translational approaches to develop novel LBP designs and microbiome-based biomarkers
- Applying clinical learnings to support early phase proof-of-concept success and build compelling evidence packages for potential collaborator engagement